Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
06/2007
06/14/2007WO2007067416A2 Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
06/14/2007WO2007066496A1 Benzoylurea compound and use thereof
06/14/2007WO2007065661A1 Biphenyl derivatives bearing an acetylene group as microbiocides
06/14/2007WO2007065281A1 Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents
06/14/2007WO2007006387A8 Onium-alkylsulfonate production method
06/14/2007US20070135634 Fluorinating agent and method for producing fluorine-containing compound using the same
06/14/2007US20070135523 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
06/14/2007US20070135498 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (1-hydroxymethyl-cyclopentyl)-amide; hypertension, atherosclerosis, unstable coronary syndrome, congestive heart failure, cardiac hypertrophy, cardiac fibrosis, cardiomyopathy postinfarction, alzheimers
06/14/2007US20070135497 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient
06/14/2007US20070135496 Substituted benzylaminoalkylene heterocycles
06/14/2007US20070135490 Phenetanolamine derivatives
06/14/2007US20070135489 Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridones
06/14/2007US20070135488 Amlodipine nicotinate and process for the preparation thereof
06/14/2007US20070135468 Pyridyloxyalkanoic acid amide derivatives useful as fungicides
06/14/2007US20070135465 Fab I Inhibitor and Process for Preparing Same
06/14/2007US20070135440 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors
06/14/2007US20070135428 Lactam containing cyclic diamines and derivatives as factor xa inhibitors
06/14/2007US20070135426 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1(2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; thromboembolic disorder like deep vein thrombosis or pulmonary embolism; pyrazolo[3,4-c]pyridine derivatives; blood coagulation factor (trypsin-like serine protease enzymes) inhibitors
06/14/2007US20070135392 Apoptosis promoters
06/14/2007US20070135367 Method for controlling sr protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control sr protein activity
06/14/2007US20070134594 Fluorescent dye and structure and manufacturing method of fluorescent storage media using thereof
06/14/2007US20070134447 Lateral a-substituted acrylate compound and polymer thereof
06/14/2007CA2632512A1 Bicyclic compounds with kinase inhibitory activity
06/14/2007CA2632476A1 Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
06/14/2007CA2630790A1 Optical determination of glucose utilizing boronic acid adducts-ii
06/14/2007CA2629913A1 Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents
06/13/2007EP1795206A1 Drug for treating or preventing hcv infection
06/13/2007EP1794127A1 Novel processes for the production of useful intermediates
06/13/2007EP1794117A2 Mercaptoamides as histone deacetylase inhibitors
06/13/2007EP1299359B1 Chemical process for the extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole
06/13/2007EP1299358B1 Pyridoxine and pyridoxal analogues as cardiovascular therapeutics
06/13/2007EP1275004B1 Mass labels
06/13/2007EP1214292B1 Tyrosine derivatives
06/13/2007CN1980923A Polycyclic pyridines as potassium ion channel modulators
06/13/2007CN1980894A Compounds and compositions as PPAR modulators.
06/13/2007CN1980893A Novel 2,6-diaminopyridine-3-one derivatives
06/13/2007CN1980892A Dpp-IV inhibitors
06/13/2007CN1980666A Process for preparing atazanavir bisulfate and novel forms
06/13/2007CN1978439A Star-shaped oligothiophene-arylene derivatives and organic thin film transistors using the same
06/13/2007CN1978438A Method for synthesizing tripoly aldehyde by ionic liquid catalysis of aldehyde
06/13/2007CN1978434A Method for preparing ionic liquid
06/13/2007CN1978430A Method for preparing 2-chloro-5-cyano pyridine
06/13/2007CN1978429A Method for treating 4 chloro pyridine in solvent
06/13/2007CN1321118C 5-aza-indole preparation method
06/12/2007US7230134 By reacting aldehydes or ketones with ammonia or primary/secondary amines in presence of hydrogen-donor and homogeneous transition metal/complex catalysts
06/12/2007US7230110 Hydroxy-, amino-, and mercapto-substituted 1-oxydihydropyridine-2-thiones; and adducts with polyvalent isocyanates, which when polymerized form microcapsule walls; for use in industrial bactericides; chemical resistance
06/12/2007US7230098 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer
06/12/2007US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
06/12/2007US7230020 For therapy of metabolic disorders, such as diabetes and obesity, cardiovascular disorders, such as hypertension, glaucoma, inflammatory disorders, such as arthritis or asthma, immune disorders, bone disorders, such as osteoporosis, cancer
06/12/2007US7230018 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof
06/12/2007US7230017 For therapy of neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems
06/12/2007US7230013 Administering taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions for inhibiting tumor growth
06/12/2007US7230009 Pyridoxal analogues and methods of treatment
06/12/2007US7230003 Aromatic prodrugs of propofol, compositions and uses thereof
06/12/2007US7229999 Pyridine-3-carboxamide derivatives as CB1 inverse agonists
06/12/2007US7229997 1-(pyridin-2-yl)-piperazine derivatives; serotonin receptor antagonists
06/12/2007US7229988 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
06/12/2007US7229702 9,9-Dimethylfluorene trimers capped with N-(9-anthracenyl- or 9-phenanthrenyl)-N-p-tolylamine used to produce an organic light-emitting device that exhibits an extremely pure luminescent hue and has a light emission of high efficiency, high brightness, and long lifetime
06/12/2007CA2354023C Phenylglycine derivatives
06/12/2007CA2282381C Process for the preparation of nicotinic acids
06/07/2007WO2007064272A1 Benzhydryl amide derivatives as cannabinoid receptor antagonists or inverse agonists
06/07/2007WO2007063925A1 2-aminobenzamide derivative
06/07/2007WO2007063839A1 Cyclohexane derivative
06/07/2007WO2007063702A2 Iminopropene compound and use thereof
06/07/2007WO2007063086A1 Novel nk1 and nk2 antagonists
06/07/2007WO2007062459A1 Selective kinase inhibitors based on pyridine scaffold
06/07/2007WO2006126939A8 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
06/07/2007WO2006010637A8 Pyridinylamines
06/07/2007US20070129550 Amino acids with affinity for the alpha-2-delta-protein
06/07/2007US20070129549 Stable lamotrigine pharmaceutical compositions and processes for their preparation
06/07/2007US20070129410 Octahydrophenanthrene hydrazinde derivatives useful as glucocorticoid receptor modulators
06/07/2007US20070129409 Androgen receptor modulators
06/07/2007US20070129392 Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
06/07/2007US20070129371 Novel ethylenediamine derivatives
06/07/2007US20070129369 Heteroaryl substituted cyclohexyl-1,4-diamine compounds
06/07/2007US20070129367 Pyridine derivatives as cb2 receptor modulators
06/07/2007US20070129361 LACTAM-CONTAINING DIAMINOALKYL, Beta-AMINOACIDS, Alpha-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS
06/07/2007US20070129338 Hydroxy-1-azobenzene derivative for treatment of thrombocytopenia
06/07/2007US20070124872 Method of coloring with capped diazotized compound and coupling component
06/07/2007CA2631741A1 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
06/07/2007CA2631693A1 Novel nk1 and nk2 antagonists
06/07/2007CA2629964A1 2-aminobenzamide derivative
06/07/2007CA2628817A1 Iminopropene compound and use thereof
06/06/2007EP1792901A1 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides
06/06/2007EP1792893A1 Aromatic amine derivative and organic electroluminescent device using same
06/06/2007EP1792624A1 Modified amino acids and compositions comprising them for delivering active agents
06/06/2007EP1791825A1 Benzoyl-substituted serine amides
06/06/2007EP1791819A1 (hetero)cyclyl(thio) carboxylic acid anilides for controlling pathogenic fungi
06/06/2007EP1791818A1 Hydrazone derivatives and their use as beta secretase inhibitors
06/06/2007EP1791811A1 Aminoalcohol derivatives
06/06/2007EP1791810A1 4-aminomethyl benzamidine derivatives and their use as factor viia inhibitors
06/06/2007EP1791427A1 (hetero)cyclylcarboxamides for controlling pathogenic fungi
06/06/2007EP1558669A4 Electroluminescent metallo-supramolecules with terpyridine-based groups
06/06/2007EP1483578A4 Artificial receptors, building blocks, and methods
06/06/2007EP1451147A4 Amino acid derivatives
06/06/2007EP1363874B1 Tryptase inhibitors
06/06/2007EP1230248B1 Transition metal complexes attached to a polymer via a flexible chain
06/06/2007EP1187833B1 Method of producing thiamethoxam
06/06/2007CN1976902A N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
06/06/2007CN1976584A Chemical compounds